KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 127 filers reported holding KYMERA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,299 | -38.9% | 5,057,425 | +1.0% | 0.01% | -37.5% |
| Q2 2023 | $115,115 | -16.7% | 5,007,148 | +7.3% | 0.02% | -23.8% |
| Q1 2023 | $138,275 | +26.5% | 4,666,681 | +6.6% | 0.02% | +16.7% |
| Q4 2022 | $109,303 | -99.9% | 4,379,159 | +6.9% | 0.02% | +20.0% |
| Q3 2022 | $89,208,000 | -13.3% | 4,097,712 | -21.6% | 0.02% | +15.4% |
| Q2 2022 | $102,874,000 | -37.6% | 5,224,686 | +34.1% | 0.01% | -23.5% |
| Q1 2022 | $164,845,000 | -26.9% | 3,895,205 | +9.7% | 0.02% | -15.0% |
| Q4 2021 | $225,423,000 | +18.7% | 3,550,528 | +9.8% | 0.02% | +11.1% |
| Q3 2021 | $189,918,000 | +112.2% | 3,233,197 | +75.2% | 0.02% | +125.0% |
| Q2 2021 | $89,479,000 | +146.8% | 1,844,926 | +97.7% | 0.01% | +100.0% |
| Q1 2021 | $36,256,000 | +49.1% | 932,978 | +138.0% | 0.00% | +100.0% |
| Q4 2020 | $24,309,000 | +155.3% | 392,076 | +33.0% | 0.00% | +100.0% |
| Q3 2020 | $9,522,000 | – | 294,695 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |